Generic for Viagra holds promise as Alzheimer’s disease treatment, Cleveland Clinic researchers say
Dec 08, 2021
Users of sildenafil are 69% less likely to develop Alzheimer’s disease than their peers who do not use the drug, investigators report. A clinical trial to confirm its benefits for Alzheimer’s patients...
Two years into pandemic, we’re better prepared to fight off virus variants
By
Alicia Lasek
Dec 02, 2021
Despite the threat of the quickly spreading and highly mutated omicron coronavirus variant — which has just landed in the U.S. — we are safer than we were before the pandemic, some experts say.
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.
Clinical briefs for Wednesday, Dec. 1
By
Alicia Lasek
Dec 01, 2021
Regeneron’s COVID-19 antibody drug may be less effective against omicron, drugmaker says … Pandemic taking toll on healthcare workers’ sleep patterns … Ambulance staffing shortage frustrating nursing...
CDC advises COVID boosters for all adults, citing worrisome omicron variant
By
Alicia Lasek
Nov 30, 2021
The new recommendation comes amid rising concerns about the omicron coronavirus variant — yet another reason to get an additional vaccine dose, health officials say.
Genesis Healthcare Friday morning announced it will replace most of its corporate leadership team and change its operational model as the post-acute provider continues to focus on its recovery.
Also in the News for Thursday, Nov. 11
Nov 11, 2021
Genesis Healthcare, Signature develop inter professional collaboration to tackle pandemic, future … NY providers urge funding boost to help with new staffing requirements … Opponents file lawsuit against...
Enrichment activities activate genes that help seniors resist cognitive decline
By
Amy Novotney
Nov 08, 2021
Spending time on intellectually stimulating activities appears to activate a gene family known as MEF2, which controls a genetic program in the brain that promotes resistance to cognitive decline. That’s...
‘Delta Plus’ variant surfaces in eight U.S. states
Nov 02, 2021
AY.4.2 ‘sub-lineage’ of delta may spread faster than the original variant, but there is no evidence that it causes more severe illness
J&J’s COVID-19 vaccine 74 percent effective, real-world study finds
By
Alicia Lasek
Nov 04, 2021
Data from more than 8,800 vaccinated Mayo Clinic patients has found that a single dose of Johnson & Johnson’s COVID-19 vaccine reduces hospitalization in the face of widely circulating gene variants.